Expired contract

NHS Midlands and East Branded Medicines - Tranche A

Details

Value
£418,787,000
Duration
2 years
Topic
Pharmaceutical products
Published
13 February 2020

Tender description

NHS Framework for the Midlands and East, Branded Medicines - Tranche A plus Cytokine Modulators and other Monoclonal Antibodies. Offer reference number: CM/PHR/16/5525 CM/PHR/16/5525/01 - NHS Framework for the Midlands and East, Branded Medicines - Tranche A, Period of framework: 1 March 2020 to 28 February 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5525/02 - NHS Framework for the Midlands and East Branded Medicines - Cytokine Modulators and other monoclonal Antibodies, Period of framework: 1 March 2020 to 28 February 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Timeline

  1. Completed: Award published13 February 2020
    Current notice
  2. Completed: Award date1 March 2020
  3. Completed: Contract expiry date28 February 2022

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

6 similar open tenders

See more open tenders related to Pharmaceutical products.

Explore all open tenders

Finding public sector work shouldn't be hard

Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.